XGN (STOCKS)
Exagen Inc. Common Stock
$4.650000
-0.020000 (-0.43%)
Prev close: $4.670000
Company Information
- Exchange
- XNAS
- Sector
- Health Services
- Industry
- Medical/Nursing Services
- CEO
- John Aballi
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $112.34M
- Employees
- 209
- P/E (TTM)
- -5.28
- P/B (TTM)
- 7.79
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
3
Strong Buy
7
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q1)
|
$-0.20 | $-0.24 | +0.0357 | +15.15% |
|
Dec 2025 (Q4)
|
$-0.20 | $-0.19 | -0.0081 | -4.22% |
|
Sep 2025 (Q3)
|
$-0.31 | $-0.16 | -0.1509 | -94.85% |
|
Jun 2025 (Q2)
|
$-0.18 | $-0.14 | -0.0363 | -25.98% |
Financial Statements
| Revenues | $68.38M |
| Benefits Costs and Expenses | $54.00M |
| Cost Of Revenue | $28.50M |
| Costs And Expenses | $54.00M |
| Gross Profit | $39.88M |
| Operating Expenses | $54.00M |
| Selling, General, and Administrative Expenses | $47.48M |
| Research and Development | $6.52M |
| Operating Income/Loss | -$14.12M |
| Income/Loss From Continuing Operations After Tax | -$20.17M |
| Income/Loss From Continuing Operations Before Tax | $5.77M |
| Income Tax Expense/Benefit | $87.00K |
| Net Income/Loss | -$20.17M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$20.17M |
| Net Income/Loss Available To Common Stockholders, Basic | -$20.17M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.89 |
| Diluted Earnings Per Share | -$0.89 |
| Basic Average Shares | 68,561,030 |
| Diluted Average Shares | 68,561,030 |
| Assets | $51.96M |
| Current Assets | $43.58M |
| Noncurrent Assets | $8.37M |
| Liabilities | $37.53M |
| Current Liabilities | $12.56M |
| Accounts Payable | $4.16M |
| Other Current Liabilities | $8.41M |
| Noncurrent Liabilities | $24.96M |
| Long-term Debt | $22.87M |
| Other Non-current Liabilities | $2.09M |
| Equity | $14.43M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $14.43M |
| Liabilities And Equity | $51.96M |
| Net Cash Flow From Operating Activities | -$13.37M |
| Net Cash Flow From Operating Activities, Continuing | -$13.37M |
| Net Cash Flow From Investing Activities | -$747.00K |
| Net Cash Flow From Investing Activities, Continuing | -$747.00K |
| Net Cash Flow From Financing Activities | $24.44M |
| Net Cash Flow From Financing Activities, Continuing | $24.44M |
| Net Cash Flow | $10.32M |
| Net Cash Flow, Continuing | $10.32M |
| Comprehensive Income/Loss | -$20.17M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$20.17M |
| Other Comprehensive Income/Loss | $0.00 |